(FATE) Fate Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Fate Therapeutics | (FATE) share price targets
Complete technical analysis of Fate Therapeutics (FATE) by charts plus indicators, forecast predictions and share price targets for Fate Therapeutics (FATE)
Fate Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Fate Therapeutics is 1521750
| Date | Daily Closing Price | Open | High | Low | Volume |
| 24 Mon Nov 2025 | 1.09 | 1.00 | 1.10 | 1.00 | 0.538 times |
| 21 Fri Nov 2025 | 1.03 | 1.00 | 1.04 | 0.97 | 0.704 times |
| 20 Thu Nov 2025 | 1.00 | 1.06 | 1.11 | 0.99 | 0.793 times |
| 19 Wed Nov 2025 | 1.05 | 0.98 | 1.08 | 0.98 | 1.011 times |
| 18 Tue Nov 2025 | 1.02 | 0.99 | 1.03 | 0.96 | 0.644 times |
| 17 Mon Nov 2025 | 0.97 | 0.98 | 1.06 | 0.96 | 1.155 times |
| 14 Fri Nov 2025 | 0.96 | 0.99 | 1.05 | 0.95 | 1.87 times |
| 13 Thu Nov 2025 | 0.98 | 1.08 | 1.10 | 0.98 | 1.378 times |
| 12 Wed Nov 2025 | 1.04 | 1.14 | 1.16 | 1.03 | 1.234 times |
| 11 Tue Nov 2025 | 1.12 | 1.09 | 1.13 | 1.06 | 0.516 times |
My analysis of stock is bearish for shortterm, and stock might move down till 1 or till 0.8. Use a stoploss of 1.13 and if the stock hits stoploss, then it can shoot up till 1.28
Share price targets for Fate Therapeutics (FATE)
| Target Type | Value |
| Downside Target | 0.91 |
| Downside Target | 0.93 |
| Downside Target | 0.95 |
| Downside Target | 1.00 |
| Downside Target | 1.05 |
| Upside Target | 1.10 |
| Upside Target | 1.16 |
| Upside Target | 1.24 |
| Upside Target | 1.27 |
| Upside Target | 1.31 |
| Upside Target | 1.34 |
| Upside Target | 1.35 |
| Upside Target | 1.51 |
| Upside Target | 1.94 |
Intraday share price targets for Fate Therapeutics (FATE)
| Target Type | Value |
| Downside Intraday Target | 1.03 |
| Downside Intraday Target | 0.96 |
| Upside Intraday Target | 1.13 |
| Upside Intraday Target | 1.16 |
| Downside Intraday Target | 1.06 |
Weekly technical analysis of Fate Therapeutics (FATE)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 24 Mon Nov 2025 | 1.09 | 1.00 | 1.10 | 1.00 | 0.125 times |
| 21 Fri Nov 2025 | 1.03 | 0.98 | 1.11 | 0.96 | 0.757 times |
| 14 Fri Nov 2025 | 0.96 | 1.10 | 1.16 | 0.95 | 0.933 times |
| 07 Fri Nov 2025 | 1.07 | 1.24 | 1.31 | 1.00 | 5.996 times |
| 31 Fri Oct 2025 | 1.35 | 1.40 | 1.51 | 1.34 | 0.105 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Fate Therapeutics (FATE)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 24 Mon Nov 2025 | 1.09 | 1.24 | 1.31 | 0.95 | 0.372 times |
| 31 Fri Oct 2025 | 1.35 | 1.25 | 1.94 | 1.13 | 1.777 times |
| 30 Tue Sep 2025 | 1.26 | 1.04 | 1.27 | 0.93 | 1.254 times |
| 29 Fri Aug 2025 | 1.04 | 1.10 | 1.24 | 0.91 | 0.965 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Fate Therapeutics (FATE)
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Fate Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Fate Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Fate Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Fate Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Fate Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.01 and Fate Therapeutics (FATE) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Fate Therapeutics (FATE) stock. Volume based technical analysis of Fate Therapeutics (FATE) stock is negative.
Fate Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Fate Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Fate Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Fate Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Fate Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Fate Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.01 and Fate Therapeutics (FATE) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Fate Therapeutics (FATE) stock. Volume based technical analysis of Fate Therapeutics (FATE) stock is negative.
Fate Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.